平安(02318.HK)参与方正集团重整 最多出资逾507亿人币
中国平安(02318.HK)公布,与各方签署方正集团重整投资协议。
根据《重整投资协议》,重整主体以除方正微电子全部权益以外的保留资产出资设立新方正集团,整体出售给投资者。根据重整主体的债权人对债权清偿方案的选择情况,非全资附属平安人寿与华发集团(代表珠海国资)将按7:3的比例受让新方正集团不低於73%的股权,不超过27%的新方正集团股权将抵偿给选择以股抵债受偿方案的债权人,重整主体持有的方正微电子全部权益由深超科技或其指定主体单独承接。
本次重整投资者最终支付对价金额及持股比例取决於债权人受偿方案选择情况,其中平安人寿将以370.5亿至507.5亿元人民币对价受让新方正集团51.1%至70%的股权。
中国平安表示,参与方正集团重整,是公司进一步深化医疗健康产业战略布局、积极打造医疗健康生态圈的重要举措,同时将与北京大学建立紧密合作关系。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.